Author Correction: Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy
Deepak Bhere, Nahid Arghiani, Esther Revai Lechtich, Yizheng Yao, Sarah Alsaab, Fengfeng Bei, Maryam M. Matin, Khalid Shah

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMicroRNA in disease regulation · Circular RNAs in diseases
Correction to: Scientific Reports 10.1038/s41598-020-58072-w, published online 04 February 2020
The Supplementary Figure file published with the original version of this Article contains errors.
As a result of an error during the figure assembly, the anti-miR21 panel at 48 hrs got duplicated from Scramble panel at 12 hrs in Gli36d panel block of Supplementary Figure 4.
Additionally, uncropped Western blots are also provided for Figure 4B.
The correct Supplementary Figure file is now linked to this correction notice.
Supplementary Information
Supplementary Legends.Supplementary Figures.
